We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

Nasdaq:ZBIO

Zenas BioPharma (ZBIO)

Nasdaq • ZBIO • US98937L1052

28.70Last close

Market Closed

Trading Signals

ORTEX Data Highlights

As of Oct 28, 2026, ORTEX estimated 24.6% of free float sold short, 20.5 days to cover, cost to borrow 0.78%. Sign up for live short interest data.

Market Cap

1.95b USD | # 3961 in US

Volume

649.63k shares | 19.13m USD

Shares Outstanding

67.82m

Free Float Shares

73.38% | 49.76m

News

ZBIO key data

Zenas BioPharma (Nasdaq: ZBIO) has a market capitalization of $1.95B. Last close $28.70 (as of 2026-11-12); 52-week range $13.50 to $44.60. ORTEX data as of 2026-10-28: short interest was 24.58% of free float, 20.5 days to cover and the average cost to borrow was 0.78%. Sign up for live short interest data.

Latest on ZBIO

May 15, 2026ZBIO CEO Buys Into an Aggressive Short Build

All ZBIO news on ORTEX News

ZBIO news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.